ArticleInternational journal of bipolar disorders2021

Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.

Teruhiko Higuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.